Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01392144 · ClinicalTrials.gov registry record
Phase II Evaluation of Exhaled Nitric Oxide (NO)
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 36
- Enrollment target
NCT01392144: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01392144 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01392144 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if the level of nitric oxide you breathe out may relate to the amount of breathing complications that you may experience due to radiation treatment.
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Nitric oxide breath test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01392144
The ClinicalTrials.gov registry entry for NCT01392144 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaires is the first listed.
NCT01392144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01392144 about?
NCT01392144 is a clinical study titled "Phase II Evaluation of Exhaled Nitric Oxide (NO)". The goal of this clinical research study is to learn if the level of nitric oxide you breathe out may relate to the amount of breathing complications that you may experience due to radiation treatment.
What is the current status of trial NCT01392144?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2011-08. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01392144?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Nitric oxide breath test (PROCEDURE).
Who is sponsoring clinical trial NCT01392144?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.